The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death.
暂无分享,去创建一个
M. Beal | A. C. Cristóvão | G. Baltazar | Yoon-Seong Kim | D. Choi | A. Cristóvão | A. C. Cristóvão | M. Flint Beal | M. F. Beal
[1] G. Bokoch,et al. Current molecular models for NADPH oxidase regulation by Rac GTPase. , 2002, Blood.
[2] R. Busse,et al. Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant , 2008, Hypertension.
[3] J. Dumont,et al. Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family* , 2000, The Journal of Biological Chemistry.
[4] E. Gazzano,et al. Classical inhibitors of NOX NAD(P)H oxidases are not specific. , 2008, Current drug metabolism.
[5] J. Andersen,et al. Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra , 2005, Journal of Biological Chemistry.
[6] J. Langston,et al. Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.
[7] C. Yabe-Nishimura,et al. PKCδ mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCδ in vascular hypertrophy , 2005 .
[8] Seung U. Kim,et al. Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo , 2005, Journal of neurochemistry.
[9] C. Yabe-Nishimura,et al. NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. , 2006, Free radical biology & medicine.
[10] M. Geiszt,et al. Involvement of Rac1 in Activation of Multicomponent Nox1- and Nox3-Based NADPH Oxidases , 2006, Molecular and Cellular Biology.
[11] Y. Agid,et al. Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.
[12] J. Lambeth,et al. Nox1-dependent Reactive Oxygen Generation Is Regulated by Rac1* , 2006, Journal of Biological Chemistry.
[13] D. Godin,et al. Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.
[14] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[15] L. Rushton,et al. Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental Health Perspectives.
[16] Wei Zhang,et al. The role of microglia in paraquat-induced dopaminergic neurotoxicity. , 2005, Antioxidants & redox signaling.
[17] J. Bus,et al. Paraquat: model for oxidant-initiated toxicity. , 1984, Environmental health perspectives.
[18] Y. Suh,et al. Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.
[19] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[20] S. Przedborski,et al. Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.
[21] C. Yabe-Nishimura,et al. The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway. , 2008, Biochemical and biophysical research communications.
[22] A Ghetti,et al. Lifestyle‐related risk factors for Parkinson's disease: a population‐based study , 2003, Acta neurologica Scandinavica.
[23] M. Duchen,et al. Expression and Modulation of an NADPH Oxidase in Mammalian Astrocytes , 2005, The Journal of Neuroscience.
[24] C. Hertzman,et al. Parkinson's disease: a case-control study of occupational and environmental risk factors. , 1990, American journal of industrial medicine.
[25] Jung-Ae Kim,et al. Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells , 2005, Free radical research.
[26] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[27] D. Graham. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. , 1978, Molecular pharmacology.
[28] Erwin G. Van Meir,et al. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. , 2001, Gene.
[29] G. Cohen,et al. Free radical mediated cell toxicity by redox cycling chemicals. , 1987, The British journal of cancer. Supplement.
[30] A. Sun,et al. Cytotoxicity of paraquat in microglial cells: Involvement of PKCδ- and ERK1/2-dependent NADPH oxidase , 2007, Brain Research.
[31] V. Uversky,et al. The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.
[32] Gang-yi Wu,et al. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus , 2005, Molecular and Cellular Neuroscience.
[33] Todd B. Sherer,et al. Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.
[34] E. Klann,et al. NADPH oxidase immunoreactivity in the mouse brain , 2003, Brain Research.
[35] K. Jellinger,et al. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease , 1992, Neuroscience Letters.
[36] V. Uversky,et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.
[37] T. Neumann-Haefelin,et al. NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke , 2007, Stroke.
[38] T. Montine,et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. , 1999, The American journal of pathology.
[39] J. Andersen,et al. Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration , 2005, Journal of neurochemistry.
[40] Dong-Hoon Shin,et al. Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain , 2005, Brain Research.
[41] A. McCormack,et al. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration , 2007, Neurobiology of Disease.
[42] C. Yabe-Nishimura,et al. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy. , 2005, The Biochemical journal.
[43] N. Cairns,et al. Apocynin improves outcome in experimental stroke with a narrow dose range , 2008, Neuroscience.
[44] M. Beal. Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[45] S. Lorenzl,et al. A pivotal role of matrix metalloproteinase‐3 activity in dopaminergic neuronal degeneration via microglial activation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] Keshav K. Singh,et al. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors , 2005, Cancer biology & therapy.
[47] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[48] F. Rossi,et al. Biochemical aspects of phagocytosis in poly-morphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells , 1964, Experientia.
[49] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[50] A. Kanthasamy,et al. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. , 2007, Neurotoxicology.
[51] Manisha N. Patel,et al. Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain* , 2007, Journal of Biological Chemistry.
[52] H. Um,et al. Link between Mitochondria and NADPH Oxidase 1 Isozyme for the Sustained Production of Reactive Oxygen Species and Cell Death* , 2006, Journal of Biological Chemistry.
[53] Colin L. Masters,et al. Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.
[54] Gary W Miller,et al. Paraquat neurotoxicity is distinct from that of MPTP and rotenone. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[55] H. Paulson,et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. , 2008, The Journal of clinical investigation.
[56] Manisha Patel,et al. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. , 2008, Free radical biology & medicine.
[57] A. Lees,et al. A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.
[58] K. Sango,et al. Reactive Oxygen Species Derived from NOX1/NADPH Oxidase Enhance Inflammatory Pain , 2008, The Journal of Neuroscience.
[59] Bin Liu,et al. Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2003, The Journal of Neuroscience.
[60] R. Davisson,et al. NADPH oxidases of the brain: distribution, regulation, and function. , 2006, Antioxidants & redox signaling.
[61] Kevin L Quick,et al. Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase , 2007, Science.